Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

The aim was to investigate the efficacy of neoadjuvant docetaxel–cisplatin and identify prognostic factors for outcome in locally advanced stage IIIA (pN2 by mediastinoscopy) non-small-cell lung cancer (NSCLC) patients. In all, 75 patients (from 90 enrolled) underwent tumour resection after three 3-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Betticher, D C, Hsu Schmitz, S-F, Tötsch, M, Hansen, E, Joss, C, von Briel, C, Schmid, R A, Pless, M, Habicht, J, Roth, A D, Spiliopoulos, A, Stahel, R, Weder, W, Stupp, R, Egli, F, Furrer, M, Honegger, H, Wernli, M, Cerny, T, Ris, H-B
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2006
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361244/
https://ncbi.nlm.nih.gov/pubmed/16622435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603075
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi